Steven Helwig
Corporate Officer/Principal bij RADIUS HEALTH, INC.
Actieve functies van Steven Helwig
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RADIUS HEALTH, INC. | Corporate Officer/Principal | 15-03-2022 | - |
| Comptroller/Controller/Auditor | 26-08-2021 | 15-03-2022 | |
| Financieel Directeur/CFO | 01-08-2015 | 15-03-2022 | |
| Treasurer | 26-08-2021 | 15-03-2022 |
Loopbaan van Steven Helwig
Statistieken
Internationaal
| Verenigde Staten | 2 |
Operationeel
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Steven Helwig
- Ervaring
